Multimodality management of recurrent rectal cancer

Clinics in Colon and Rectal Surgery

Volumn 15, Issue 1, 2002, Pages 63-70

  Belluco, Claudio ^a   Melega, Enrico ^a   Mammano, Enzo ^a   Pucciarelli, Salvatore ^a   Nitti, Donato ^a   Lise, Mario ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chemotherapy; Multimodality treatment; Radiotherapy; Recurrent rectal cancer; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE INHIBITOR; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; RALTITREXED; THYMIDYLATE SYNTHASE INHIBITOR;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL EXAMINATION; CLINICAL PROTOCOL; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; INOPERABLE CANCER; MULTIMODALITY CANCER THERAPY; ONCOLOGY; PELVIS; PREOPERATIVE EVALUATION; RECTOSCOPY; RECTUM CANCER; REVIEW;

EID: 0036202640     PISSN: 15310043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-23569     Document Type: Review

References (66)

1. The value of adjuvant radio(chemo)therapy for rectal cancer
2. Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon
3. Local recurrence of colorectal cancer: The problem, mechanism, management and adjuvant therapy
4. Local recurrence after curative colorectal adenocarcinoma
5. Patterns of pelvic recurrence following definitive resections of rectal cancer
6. Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer
7. Surgical salvage of recurrent rectal carcinoma after curative resection: A 10-year experience
8. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers
9. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer
10. Irinotecan in the treatment of colorectal cancer. Clinical overview
11. Tomudex (ZD 1694), a novel thymidylate syntase inhibitor has substantial activity in the treatment of patients with advanced colorectal cancer
12. Oxaliplatin a new agent for colorectal cancer
13. Is follow-up of colorectal cancer patients worthwhile?
14. Local recurrence of colorectal cancer: Effect of early detection and aggressive surgery
15. Strategies in operative therapy for locally recurrent rectal cancer
16. CT vs MRI in diagnosis of recurrent rectosigmoid carcinoma
17. Local recurrence of rectosigmoid cancer: What about the choice of MRI for diagnosis?
18. Positron emission tomography for preoperative staging of colorectal carcinoma
19. Clinical value of whole-body positron emission tomography with [18F] fluoro-deoxyglucose in recurrent colorectal cancer
20. Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging
21. The role of whole-body positron emission tomography with [18F] fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver
22. PET studies of fluoro-deoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy
23. Added value of CEA scintigraphy in the detection of recurrence of rectal carcinoma
24. Radioimmunoguided surgery benefits for recurrent colorectal cancer
25. Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancer
26. Pelvic exenteration for recurrent colorectal carcinoma: A review
27. Surgery for local recurrence of rectal carcinoma
28. Locally recurrent rectal cancer. Predictors and success of salvage surgery
29. Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma
30. Curative reoperations for locally recurrent rectal cancer
31. Abdominosacral resection for primary irresectable and locally recurrent rectal cancer
32. Treatment of local recurrence of rectal cancer
33. Role of carcinoembryonic antigen in predicting resectability of recurrent colorectal cancer
34. Aggressive surgical management of locally advanced primary and recurrent rectal cancer
35. Surgical resection for locally recurrent colorectal adenocarcinoma
36. Abdominosacral resection of recurrent rectal cancer in the sacrum
37. Pelvic resection of recurrent rectal cancer
38. The role of pallitative pelvic exenteration
39. Prognostic factors in surgery for local recurrence of rectal cancer
40. Aggressive surgical management of recurrent rectal cancer: Is it worthwhile?
41. Second-look surgery for colorectal cancer
42. Total pelvic exenteration and rectal cancer. Apropos of 20 cases
43. Surgery for local recurrence from rectal cancer
44. Curative surgical resection following reirradiation for recurrent rectal cancer
45. Results and complications of surgery combined with intraoperative radiation therapy for the treatment of locally advanced or recurrent cancer in the pelvis
46. Intraoperative irradiation for locally advanced colorectal carcinomas
47. High dose rate intraoperative radiation therapy for colorectal cancer
48. High dose rate intraoperative radiation therapy for colorectal cancer
49. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma
50. Intraoperative irradiation after surgery for locally recurrent rectal cancer
51. Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma
52. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer
53. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer
54. Extensive surgery after high-dose chemoradiotherapy for locally advanced recurrent rectal cancer
55. Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: Clinical and dose-response analysis
56. The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on outcome of patients with locally advanced primary rectal and rectosigmoid cancer
57. Sacropelvic resection and intraoperative electron irradiation in the management of recurrent anorectal cancer
58. Surgical complications of intraoperative radiation therapy; the Radiation Therapy Oncology Group Experience
59. Radiotherapy of presacral recurrence following radical surgery for rectal carcinoma
60. Symptomatic recurrence of carcinoma of the rectum and sigmoid: The influence of radiotherapy on the quality of life
61. Palliative reirradiation for recurrent rectal cancer
62. Use of brachytherapy in management of locally recurrent rectal cancer
63. Cryosurgery for locally recurrent rectal cancer
64. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer
65. Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer
66. The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices